Safety of dipyrone (metamizole) in children-What's the risk of agranulocytosis?
Paediatr Anaesth
.
2018 Feb;28(2):186-187.
doi: 10.1111/pan.13312.
Authors
Victoria C Ziesenitz
1
,
Thomas O Erb
2
,
Daniel Trachsel
3
,
Johannes N van den Anker
1
Affiliations
1
Division of Paediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland.
2
Division of Paediatric Anaesthesiology, University of Basel Children's Hospital, Basel, Switzerland.
3
Division of Paediatric Pulmonology and Intensive Care, University of Basel Children's Hospital, Basel, Switzerland.
PMID:
29345086
DOI:
10.1111/pan.13312
No abstract available
Publication types
Letter
Comment
MeSH terms
Agranulocytosis*
Anti-Inflammatory Agents, Non-Steroidal
Child
Dipyrone*
Humans
Risk
Substances
Anti-Inflammatory Agents, Non-Steroidal
Dipyrone